Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Sale | 2024-02-14 6:43 pm | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $31.97 | $191,849 | 55,000 (Direct) | View |
| 2024-01-19 Sale | 2024-01-22 6:59 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 18,403 | $23.67 | $435,645 | 446,597 (Direct) | View |
| 2024-01-16 Sale | 2024-01-16 7:07 pm | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 10,000 | $23.58 | $235,806 | 135,109 (Direct) | View |
| 2024-01-16 Sale | 2024-01-16 7:07 pm | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $23.58 | $117,898 | 107,000 (Direct) | View |
| 2024-01-10 Sale | 2024-01-10 8:35 pm | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $23.86 | $143,144 | 61,000 (Direct) | View |
| 2023-12-18 Sale | 2023-12-18 8:04 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $21.48 | $243,441 | 15,000 (Direct) | View |
| 2023-12-15 Sale | 2023-12-15 4:38 pm | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 21,497 | $21.99 | $472,646 | 145,109 (Direct) | View |
| 2023-12-15 Sale | 2023-12-15 4:35 pm | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $21.98 | $109,903 | 112,000 (Direct) | View |
| 2023-12-11 Sale | 2023-12-11 7:03 pm | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,865 | $20 | $1,297,170 | 171,301 (Direct) | View |
| 2023-12-11 Sale | 2023-12-11 7:01 pm | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $20.07 | $120,422 | 67,000 (Direct) | View |
| 2023-11-17 Sale | 2023-11-17 5:58 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $18.28 | $207,293 | 26,332 (Direct) | View |
| 2023-11-15 Sale | 2023-11-17 5:57 pm | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $17.38 | $86,889 | 117,000 (Direct) | View |
| 2023-11-13 Sale | 2023-11-14 6:00 pm | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,863 | $15.89 | $1,030,660 | 236,166 (Direct) | View |
| 2023-11-10 Sale | 2023-11-14 5:56 pm | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 7,000 | $15.24 | $106,700 | 73,000 (Direct) | View |
| 2023-10-18 Sale | 2023-10-18 6:22 pm | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $14.07 | $305,941 | 37,674 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-22 Disposition | 2024-03-22 5:09 pm | N/A 2027-01-18 | CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director | 283,460 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 5:06 pm | N/A 2025-01-06 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 1,735,350 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 5:05 pm | N/A 2032-03-20 | CymaBay Therapeutics Inc. | CBAY | Lefebvre Eric Director | 154,010 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 5:03 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 161,010 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 5:03 pm | N/A 2033-05-21 | CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer | 454,875 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 5:02 pm | N/A 2027-06-27 | CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer | 1,322,111 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:59 pm | N/A 2030-10-11 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 753,230 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:55 pm | N/A 2025-04-15 | CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director | 362,460 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:55 pm | N/A 2025-01-06 | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 4,432,651 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:54 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 186,010 | $0 | 0 (Direct) | View |
| 2024-03-22 Disposition | 2024-03-22 4:51 pm | N/A 2025-01-06 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 370,460 | $0 | 0 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 2,288 | $5.78 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 52,084 | $1.72 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 18,899 | $9.21 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 3,125 | $11.69 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 22,076 | $4.05 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 14,372 | $8.43 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 11,649 | $10 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 1 | $2.94 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 14,625 | $1.06 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:03 pm | N/A 2025-01-06 | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 139,119 | $0 | 455,314 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:02 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 41,824 | $7.89 | 79,134 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:02 pm | N/A 2030-10-11 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 41,824 | $0 | 79,134 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:43 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $0 | 55,000 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-14 6:43 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $4.63 | 55,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:33 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Shantharam Harish Chief Financial Officer | 94,875 | $0 | 94,875 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:30 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Dickinson Klara Chief Regulatory Officer | 99,000 | $0 | 99,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:29 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 150,563 | $0 | 165,563 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:28 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 134,063 | $0 | 134,063 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:27 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 453,750 | $0 | 625,051 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:20 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Wills Robert James Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:19 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:18 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | WIGGANS THOMAS G Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:17 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Loewy Caroline M Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:16 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | Lefebvre Eric Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 6:10 pm | N/A 2034-01-23 | CymaBay Therapeutics Inc. | CBAY | EMSTER KURT VON Director | 14,010 | $0 | 14,010 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 2,778 | $1.72 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 1,916 | $1.82 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 3,125 | $11.69 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 8,334 | $10 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 2,250 | $1.06 | 446,597 (Direct) | View |
| 2024-01-19 Exercise | 2024-01-22 6:59 pm | N/A 2026-01-25 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 18,403 | $0 | 446,597 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-16 7:07 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 10,000 | $4.05 | 135,109 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-16 7:07 pm | N/A 2030-05-14 | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 10,000 | $0 | 135,109 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-16 7:07 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $2.94 | 107,000 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-16 7:07 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $0 | 107,000 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-10 8:35 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $0 | 61,000 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-10 8:35 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $4.63 | 61,000 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-18 8:04 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $5 | 15,000 (Direct) | View |
| 2023-12-18 Exercise | 2023-12-18 8:04 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,332 | $0 | 15,000 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-15 4:38 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 10,000 | $4.05 | 145,109 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-15 4:38 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 11,497 | $8.43 | 145,109 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-15 4:38 pm | N/A 2030-05-14 | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 21,497 | $0 | 145,109 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-15 4:35 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $2.94 | 112,000 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-15 4:35 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $0 | 112,000 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-11 7:03 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,865 | $5 | 171,301 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-11 7:03 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,865 | $0 | 171,301 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-11 7:01 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $0 | 67,000 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-11 7:01 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 6,000 | $4.63 | 67,000 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-17 5:58 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $5 | 26,332 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-17 5:58 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 11,342 | $0 | 26,332 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:57 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 17,500 | $3.45 | 0 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:57 pm | N/A 2027-05-02 | CymaBay Therapeutics Inc. | CBAY | Menold Daniel Vice President, Finance | 17,500 | $0 | 0 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:57 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $2.94 | 117,000 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:57 pm | N/A 2032-01-24 | CymaBay Therapeutics Inc. | CBAY | Quinlan Paul T General Counsel | 5,000 | $0 | 117,000 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:00 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,863 | $5 | 236,166 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:00 pm | N/A 2023-12-22 | CymaBay Therapeutics Inc. | CBAY | Shah Sujal Chief Executive Officer | 64,863 | $0 | 236,166 (Direct) | View |
| 2023-11-10 Exercise | 2023-11-14 5:56 pm | N/A 2031-04-04 | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 7,000 | $0 | 73,000 (Direct) | View |
| 2023-11-10 Exercise | 2023-11-14 5:56 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | Dorling Janet Director | 7,000 | $4.63 | 73,000 (Direct) | View |
| 2023-10-18 Exercise | 2023-10-18 6:22 pm | N/A N/A | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $5 | 37,674 (Direct) | View |
| 2023-10-18 Exercise | 2023-10-18 6:22 pm | N/A 2023-10-30 | CymaBay Therapeutics Inc. | CBAY | McWherter Charles President of R&D | 21,743 | $0 | 37,674 (Direct) | View |